Center for Biologics Evaluation and Research (CBER) issued Moderna a refusal-to-file letter for its mRNA influenza vaccine, mRNA-1010. Two weeks later, under mounting pressure from the scientific ...
Morning Overview on MSN
New mRNA flu shot proves 30%+ more powerful at stopping influenza A
Moderna says its experimental mRNA influenza vaccine, mRNA-1010, showed more than 30% greater relative vaccine efficacy against influenza A than a licensed egg-based flu shot in a large Phase 3 trial ...
Morning Overview on MSN
FDA agrees to evaluate Moderna mRNA flu vaccine after initial refusal
The U.S. Food and Drug Administration has agreed to evaluate Moderna’s investigational mRNA-based seasonal influenza vaccine, mRNA-1010, reversing a refusal-to-file decision it issued just weeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results